The data shown below were collected from the profiles of 61 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
|
---|---|
Published in |
Journal for Immunotherapy of Cancer, July 2019
|
DOI | 10.1186/s40425-019-0662-5 |
Pubmed ID | |
Authors |
Ezra E. W. Cohen, R. Bryan Bell, Carlo B. Bifulco, Barbara Burtness, Maura L. Gillison, Kevin J. Harrington, Quynh-Thu Le, Nancy Y. Lee, Rom Leidner, Rebecca L. Lewis, Lisa Licitra, Hisham Mehanna, Loren K. Mell, Adam Raben, Andrew G. Sikora, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg, Robert L. Ferris |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 22 | 36% |
Spain | 8 | 13% |
Australia | 3 | 5% |
United Kingdom | 2 | 3% |
Colombia | 1 | 2% |
Canada | 1 | 2% |
Turkey | 1 | 2% |
India | 1 | 2% |
Greece | 1 | 2% |
Other | 5 | 8% |
Unknown | 16 | 26% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 31 | 51% |
Practitioners (doctors, other healthcare professionals) | 17 | 28% |
Scientists | 11 | 18% |
Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 370 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 370 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 36 | 10% |
Student > Ph. D. Student | 34 | 9% |
Other | 32 | 9% |
Student > Bachelor | 29 | 8% |
Student > Doctoral Student | 22 | 6% |
Other | 59 | 16% |
Unknown | 158 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 109 | 29% |
Biochemistry, Genetics and Molecular Biology | 34 | 9% |
Agricultural and Biological Sciences | 16 | 4% |
Immunology and Microbiology | 10 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 2% |
Other | 24 | 6% |
Unknown | 169 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 160. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2024.
All research outputs
#276,285
of 26,726,803 outputs
Outputs from Journal for Immunotherapy of Cancer
#51
of 3,609 outputs
Outputs of similar age
#5,126
of 363,291 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 88 outputs
Altmetric has tracked 26,726,803 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,609 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,291 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.